They worded it as if they had because of a better product range but who knows.
Revenues should pick up this quarter I'm and I'm hearing lots of news on the cannabis front is imminent.
I think the cannabis side of the business will be an immediate money earner through finished products and then in the future a bigger earner through targeting more serious illnesses post chemo and so on.
Other products slowly making there way to market also under the companies own banner. A lot more margins there as well.
BDA Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
